Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Holders of 5% or more of VRCA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Verrica Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Manning Paul B | 13D/A | 49.90%8.06M shares | – | Nov 28, 20251 filing | Nov 28, 2025 | SEC |
| Caligan Partners LP | 13G | 9.99%15.9M shares | New | Feb 12, 20251 filing | Feb 12, 2025 | SEC |
| Caligan Partners LP | 13D/A | 9.99%6.50M shares | 0.00 ppfrom 9.99% | Nov 24, 20252 filings | Dec 30, 2025 | SEC |
| Affinity Asset Advisors, LLC | 13G/A | 5.50%884.2K shares | +0.03 ppfrom 5.47% | Dec 3, 20252 filings | Jan 29, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on Verrica Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20269:39 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%439.7K shares | −1.78 ppfrom 6.77%Below 5% | Dec 31, 2025 | SEC |
| Jan 29, 20267:59 PM ET | Affinity Asset Advisors, LLCand 1 other | 13G/A | 5.50%884.2K shares | +0.03 ppfrom 5.47% | Jan 22, 2026 | SEC |
| Dec 30, 20257:10 AM ET | Caligan Partners LPand 1 other | 13D/A | 9.99%6.50M shares | 0.00 ppfrom 9.99% | Dec 26, 2025 | SEC |
| Dec 3, 20253:20 PM ET | Affinity Asset Advisors, LLCand 1 other | 13G | 5.47%884.2K shares | New | Nov 25, 2025 | SEC |
| Nov 28, 20255:10 PM ET | Manning Paul Band 2 others | 13D/A | 49.90%8.06M shares | – | Nov 25, 2025 | SEC |
| Nov 24, 20254:15 PM ET | Caligan Partners LPand 1 other | 13D | 9.99%6.50M shares | New | Nov 23, 2025 | SEC |
| Nov 14, 20256:29 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 6.77%639.2K shares | −3.22 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Aug 14, 20259:41 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%9.24M shares | 0.00 ppfrom 9.99% | Mar 31, 2025 | SEC |
| May 15, 20254:30 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 1.60%1.48M shares | −3.50 ppfrom 5.10%Below 5% | Mar 31, 2025 | SEC |
| May 15, 20253:20 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%9.24M shares | 0.00 ppfrom 9.99% | Mar 31, 2025 | SEC |
| Feb 14, 20255:01 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%9.13M shares | New | Dec 31, 2024 | SEC |
| Feb 14, 20254:15 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 5.10%4.73M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20254:05 PM ET | Caligan Partners LPand 1 other | 13G | 9.99%15.9M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Verrica Pharmaceuticals Inc. shares.
No Form 144 notices for Verrica Pharmaceuticals Inc. are on file.